|
US6004980A
|
|
(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
|
|
US5955470A
|
|
Derivatives of amide analogs of certain methano bridged quinolizines
|
|
CN1204648A
|
|
Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents
|
|
US6005071A
|
|
Anticoagulant peptides
|
|
US6114380A
|
|
Difluoro statone analogs
|
|
US5830863A
|
|
Neurokinin A antagonists
|
|
MX9605344A
|
|
Process for the preparation of 1-(3-trialkylsilylphenyl)-2,2,2-trifluoromethyl ethanone derivatives.
|
|
US5807742A
|
|
Neurokinin receptor cell lines
|
|
EP0796619A1
|
|
Use of (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol in treating depressive disorders and bipolar disorders
|
|
US5834433A
|
|
Compounds and pharmaceutical uses of peptides of bombesin and GRP
|
|
US5670521A
|
|
Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives
|
|
CA2198084A1
|
|
Novel substituted piperidines useful for the treatment of allergic diseases
|
|
EP0749972A1
|
|
A process for preparing 1-(3-trialkylsilylphenyl)-2,2,2-trifluoromethyl ethanone derivatives
|
|
US5714470A
|
|
Orally-active elastase inhibitors
|
|
US5670144A
|
|
Anti-herpes virus and cytomegalovirus polyester oligomers
|
|
US5494912A
|
|
9-purinyl phosphonic acid derivitives for treating gout
|
|
MX9700414A
|
|
Difluorostatone antiviral agents.
|
|
US5606063A
|
|
NMDA antagonists
|
|
US6147216A
|
|
Intermediates useful for the preparation of antihistaminic piperidine derivatives
|
|
HU9700026D0
|
|
Process for producing 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thion derivatives
|
